Oncternal Therapeutics, Inc. (ONCT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 31.52M |
| Enterprise Value | 25.14M |
| P/E Ratio | -0.04 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.99 |
| Price/Book Ratio | 0.05 |
| Enterprise/Revenue | -6.14 |
| Enterprise/EBITDA | -2.16 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
| Profit Margin | -50.29 |
| Operating Margin | -53.14 |
| Return On Assets | -1.07 |
| Return On Equity | 0.62 |
| Revenue | 785,000 |
| Revenue/Share | 0.27 |
| Gross Profit | -28.97M |
| EBITDA | 2.24M |
| Net Income | -39.48M |
| Diluted EPS | -13.43 |
| Total Cash | 14.58M |
| Total Cash/Share | 11.65 |
| Total Debt | 191,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 6.94 |
| Book Value Per Share | 10.22 |
| 52-Week Change | -95.25 |
| 52-Week High | 10.61 |
| 52-Week Low | 0.53 |
| Moving Average 50 Days | 0.53 |
| Moving Average 200 Days | 3.8 |
| Average Volume | 62,268 |
| Shares Outstanding | 2.96M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 08, 2024 |